Navigation Links
Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
Date:1/24/2008

Doctors Are Combining Portrait(R) Plasma with Fractionated Lasers Or in

Place of Surgery to Alleviate the Signs of Aging of the Eyes

WALTHAM, Mass., Jan. 24 /PRNewswire/ -- When it comes to the aging eye area, going under the knife is no longer the only option. According to the American Academy of Facial and Plastic Surgery, surgeons are seeing a more educated patient who is interested in non-surgical options to obtain the best results. One of the most requested aesthetic treatments is wrinkle reduction and tightening around the eyes and the excess tissue of the upper eyelid. For patients who experience sagging, droopy eye lids, wrinkles and puffiness, blepharoplasty (eyelid surgery) is no longer the only option to obtain a more youthful eye area.

One solution offered by Dr. Brian Biesman, Ophthalmic Plastic and Reconstructive Surgeon of Nashville Centre for Laser and Facial Surgery in Nashville, Tennessee, is a cosmetic combination that helps patients reap maximum benefits from their treatment; blepharoplasty, Portrait Plasma, a novel plasma skin regeneration technology, and injectables such as Botox and fillers.

"Blepharoplasty removes the excess tissue and skin, but Portrait Plasma improves skin quality. It smoothes fine lines and treats both wrinkles and sun damage, which surgery alone cannot do," according to Dr. Biesman. Additionally he indicated injectables may be used to relax the muscles and then, in some cases, filler may be used to enhance volume. Physicians are also combining Portrait with other aesthetic procedures, such as fractionated lasers, a popular treatment that does not meet patient's demands for improvement in the peri-orbital area. Richard Fitzpatrick, MD from La Jolla Cosmetic Surgery Centre combines Portrait(R) Plasma with fractional laser for further results on the face. At times he chooses Portrait Plasma for treating eyes over other devices in his practice remarking, "Eyelid skin is uniquely suited for
'/>"/>

SOURCE Rhytec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
2. GSK Does Not Option XL784 for Further Development
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
7. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
8. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
9. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
10. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
11. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...irstCall/--Hologic,Inc.(HologicortheCompany)(Nasda...rofpremiumdiagnostics,medicalimagingsystemsandsurg...women,isusingtheannualmeetingoftheRadiologicalSoci...ovember29throughDecember3,2009tohighlightournewSec...workstationsoftware. ,, TheHologicSecurViewwork...
(Date:11/25/2009)...TrendsResearchGroup,Inc.releasedWave1ofits Launch...asesyndicatedmarketresearchprojecttrackingthelaunc...hthroughthefirstsixmonthsofavailability.Eachwaveof...ueDermatologistsandqualitativeinformationfromasubs...lestouse,typicalpatienttypes,productperceptions,pr...
(Date:11/25/2009)...swire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAm...daythatitreceivedtheEnvironmentalResponsibilityand...alSummit,sponsoredbytheCaliforniaManufacturersandT...talAssociation(IEA)andtheChemicalIndustryCouncilof...giousawardavailablefromallthreeorganizationsandgai...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2McGill JGH researchers successfully reverse multiple sclerosis in animals 9531 1McGill JGH researchers successfully reverse multiple sclerosis in animals 9531 2Partnership to Fight Chronic Disease Analyzes Key Provisions in Health Care Legislation Released To Date 54208 1Partnership to Fight Chronic Disease Analyzes Key Provisions in Health Care Legislation Released To Date 54208 2Hospira Launches Generic Oxaliplatin Injection 54204 1Hospira Launches Generic Oxaliplatin Injection 54204 2Hospira Launches Generic Oxaliplatin Injection 54204 3
..., June 3 Delcath Systems, Inc.,(Nasdaq: DCTH ) a...f,Bethlehem, PA, part of St. Luke,s Hospital & Hea...e III clinical trial for the treatment of,inoperab...any,s,Percutaneous Hepatic Perfusion (PHP) System ...ancer agent melphalan. This Phase III multi-center...
...boomers age drug-free treatments receive renewed a...D, FACS, FAAP to begin Plantar ...BioElectronics Corp.,(BIEL), the maker of the Acti...th an embedded battery operated microchip deliveri... to speed healing, today announced that,recent sal...
Other Medicine Technology:Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 3BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 2BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 3BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 4BioElectronics Announces Profitability Breakeven and Additional Clinical Trials 5
(Date:11/25/2009)...fortuitous discovery that grew out of a collaborat...tentially offer hope to the nearly 10 million Amer... , Also known as hardening of the arteries, ...irculatory problem in which narrowed arteries redu...dered a red flag for vascular disease, heart attac...
(Date:11/25/2009)...mab, already used to fight rheumatoid arthritis, c..., , WEDNESDAY, Nov. 25 (HealthDay News) -...homa and rheumatoid arthritis now also shows some ...ype 1 diabetes. , The drug, rituximab (Rituxan)... insulin, even though the disease had destroyed so...
(Date:11/25/2009)...ors often plagued by neurological symptoms, study ... News) -- Neurological side effects are among the ... testicular cancer who were treated with cisplatin...he study included 1,409 Norwegian men treated for ... who took part in a follow-up survey conducted fro...
(Date:11/25/2009)..., ARLINGTON,Va.,Nov.25/PRNewswire-USNewswire/--The...ntHealthCareFraudActof2009,"S.2128,whichisdesigned...preventfraudinMedicare.ThebillwasintroducedbySen.G...severalprovisionstheAmericanAssociationforHomecare...AssociationproposedtoCongressinFebruary.Thoseprovi...
(Date:11/25/2009)...ug used to treat colorectal cancer also can revers... first-line therapy for the disease, researchers a... week. , Mntrier,s disease causes thickening of t...nd vomiting, as well as anemia and swelling in the... at increased risk for gastric cancer. Previously,...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...sophageal reflux disease (GERD) is a common disord...%. The diagnosis and treatment of GERD are therefo...he highly disturbing typical symptoms, has a serie...carcinoma. , Although many investigators have rep...
... rinse of the airway beats saline sprays at provid...ay News) -- Saline irrigation is a safe, inexpensi... and sinus symptoms, according to a new study. , ...ure -- is more effective than commonly used saline...
... Iceland, Nov. 23 deCODE genetics,(Nasdaq: DCGN ... of deCODE,CEO Kari Stefansson,s presentation at t...he presentation will be delivered at 9:00 am EST o...code.com, and those,interested in listening shoul...
...ed water could boost child,s cancer risk, study fi... of women exposed to arsenic-contaminated water du...ay result in cancer and other diseases later in li...changes caused by prenatal exposure to an environm...
... revealing how berry helps ward off infection , TH...on your Thanksgiving dinner plate may be more than...o, scientists say. , Compounds in cranberries may ...decay -- say researchers at Worcester Polytechnic ...
...D, Calif. - Researchers at the Stanford University...cant step, in mouse studies, toward the goal of tr...e system for people with autoimmune or genetic blo...e systems. Many aspects of the technique would nee...
Other Medicine News:Health News:Saline Irrigation Eases Chronic Nasal Symptoms 2Health News:Cranberry Sauce May Be Healthy Treat 2Health News:Stem cell transplant can grow new immune system in certain mice, Stanford researchers find 2
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: